Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate

Journal of Urology

Volumn 160, Issue 5, 1998, Pages 1872-1876

  Hashimoto, Kunihiro ^a   Kihira, Yasunori ^b   Matuo, Yuhsi ^b   Usui, Tsuguru ^b  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Matrix metalloproteinase 7; Prostate carcinoma; Tissue inhibitor of metalloproteinase 1

Indexed keywords

MATRILYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; AUTORADIOGRAPHY; CANCER INVASION; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE EPITHELIUM;

EID: 0008427936     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)62435-2     Document Type: Article

References (29)

1. Woessner, F. J. Jr.: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J., 5: 2145, 1991.
2. Nagase, H.: The control system of activation of MMP-7. Pure Chemicals "Daiichi", 26: 9, 1995.
3. Imai, K., Yokohama, Y., Nakanishi, I., Ohuch, E. and Fujii, Y.: Matrix metalloproteinase 7 (Matrilysin) from human rectal carcinoma cells. J. Biol. Chem., 270: 6691, 1995.
4. Ohuchi, E., Azumano, I., Yoshida, S., Iwata, K. and Okada, Y.: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 7 (Matrilysin) using monoclonal antibodies. Clin. Chim. Acta, 244: 181, 1996.
5. McDonnel, S., Navre, M., Coffey, R. J. Jr. and Matrisian, L. M.: Expression and localization of the matrix metalloproteinase pump-1(MMP-7) in human gastric and colon carcinoma. Mol. Carcinogen., 4: 527, 1991.
6. Yoshimoto, M., Itoh, F., Yamamoto, H., Hinoda, Y., Imai, K. and Yachi, A.: Expression of MMP-7(pump-1) mRNA in human colorectal cancers. Int. J. Cancer, 54: 614, 1993.
7. Pajouh, M. S., Nagle, R. B., Breathnach, R., Finch, J. S., Brawer, M. K. and Bowden, G. T.: Expression of metalloproteinase genes in human prostate cancer. J. Cancer Res. Clin. Oncol., 117: 144, 1991.
8. Matrisian, L. M.: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet., 6: 121, 1990.
9. Liotta, L. M. and Stetler-Stevenson, W. G.: Tumor invasion and metastasis. Cancer Res., 51: 5054, 1991.
10. Davis, B., Miles, D. W., Happerfield, L. C., Naylor, M. S., Bobrow, L. G., Rubens, R. D. and Balkwill, F. R.: Activity of type IV collagenases in benign and malignant breast disease. Br. J. Cancer, 67: 1126, 1993.
11. Miyazaki, K., Hattori, Y., Umenishi, F., Yasumitsu, H. and Umenida, M.: Pulification and characterization of extracellular matrix-degrading metalloproteinase, Matrin (Pump-1), secreted from human rectal carcinoma cell line. Cancer Res., 50: 7758, 1990.
12. Stamey, T. A.: Second Stanford conference on international standardization of prostate-specific antigen immunoassays. Urology, 45: 173, 1994.
13. Kuriyama, M., Yamamoto, N., Shinoda, I., Kawada, Y., Akimoto, S. and Shimazaki, J.: Clinical evaluation of tandem PSA in Japanese cases and comparison with other methods. Acta Urol. Jap., 41: 39, 1995.
14. Powell, W. C., Kno, J. D., Narve, M., Grogan, T., Kittelson, J., Nagle, R. B. and Bowden, G. T.: Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res., 53: 417, 1993.
15. Stearns, M. E. and Wang, M.: Type IV collagenase (Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res., 53: 878, 1993.
16. Lokeshwar, B. L., Selzer, M. G., Block, N. L. and Gunja-Smith, Z.: Secretion of matrix metalloproteinases and their inhibitors (tissue inhibitor of metalloproteinases) by human prostate in explant cultures: reduced tissue inhibitor of metalloproteinases secretion by malignant tissues. Cancer Res., 53: 4493, 1993.
17. Festuccia, C., Bolongna, M., Vicentini, C., Tacconelli, A., Miano, R., Violin, S. and Mackay, A. R.: Increased matrix metalloproteinase-9 secretion in short-term tissue cultures of prostatic tumor cells. Int. J. Cancer, 69: 386, 1996.
18. Imai, K., Yokohama, Y., Nakanishi, I., Ouchi, E., Fujii, Y., Nakai, N. and Okada, Y.: Matrix metalloproteinase 7 (Matrilysin) from human rectal carcinoma cells. J. Biol. Chem., 270: 6691, 1995.
19. Crabbe, T., Smith, B., O'Connel, J. and Docherty, A.: Human pro-gelatinase A can be activated by matrilysin. FEBS Lett., 345: 14, 1994.
20. Liotta, L. A., Steeg, P. S. and Stetler-Stevenson, W. G.: Cancer metastasis angiogenesis: an imbalance of positive and negative regulation. Cell, 64: 327, 1991.
21. Itoh, F., Yamamoto, H., Hinoda, Y. and Imai, K.: Enhanced secretion and activation of matrilysin during malignant conversion of human colorectal epithelium and its relationship with invasive potential of colon cancer cells. Cancer (Suppl.), 77: 1717, 1997.
22. Hashimoto, K., Yano, A., Tanabe, T., Kihira, Y., Matsuo, Y. and Usui, T.: Localization and expression of matrix metalloproteinase-7 in human prostate tissues. Jpn. J. Urol., 10: 852, 1997.
23. Koshikawa, N., Yasumitsu, H., Umeda, M. and Miyazaki, K.: Multiple secretion of matrix serine proteinases by human gastric carcinoma cell lines. Cancer Res., 52: 5046, 1992.
24. Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E. and Iwata, K.: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett., 298: 29, 1992.
25. Jung, K., Nowak, N., Lein, M., Priem, F., Schnorr, D. and Loening, S. A.: Matrix metalloproteinase-1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer. Int. J. Cancer, 74: 220, 1997.
26. Zeng, Z. S., Cohen, A. M., Zhang, Z. F., Stetler-Stevenson, W. G. and Gullen, J. G.: Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastasis. Clin. Cancer Res., 1: 899, 1995.
27. Oesterling, J. E., Andrews, P. E., Suman, V. J., Zincke, H. and Myers, R. P.: Preoperative androgen deprivation therapy: Artificial lowering of serum prostate specific antigen without downstaging the tumor. J. Urol., 149: 779, 1993.
28. Saarialho-Kere, U. K., Crouch, E. C. and Parks, W. C.: Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. Invest. Derm., 105: 190, 1995.
29. Shiina, H., Igawa, M., Shigeno, K., Wada, Y., Yoneda, T., Shirakawa, H., Ishibe, T., Shirakawa, R., Nagasaki, M., Shirane, T. and Usui, T.: Immunohistochemical analysis of estramustine binding protein with particular reference to proliferative activity in human prostatic carcinoma. Prostate, 32: 49, 1997.